<DOC>
	<DOC>NCT02792764</DOC>
	<brief_summary>This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.</brief_summary>
	<brief_title>Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs</brief_title>
	<detailed_description />
	<criteria>Male or female, age â‰¥ 21 years Subject is currently undergoing or has had infusional cancer therapy (solid tumor or hematologic) through a Bard PORT with a distallyvalved catheter/openended catheter or infusion through a PIV Subject had a chemotherapy regimen consisting of a vesicant and/or irritant Subject has signed an Informed Consent Form (ICF) or has had an ICF signed by the subject's legally authorized representative Subject has/had an implanted non Bard PORT</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>port</keyword>
	<keyword>peripheral intravenous lines</keyword>
	<keyword>oncology</keyword>
</DOC>